Evidence map›Paper›PMID 36326947›Full record

ArticleClinical rheumatology2023

Scoping beyond pulmonary artery involvement; pulmonary involvement in Behcet's disease; a retrospective analysis of 28 patients.

Reşit Yıldırım, Sedanur Oğuzman, Mustafa Dinler, Nazife Şule Yaşar Bilge, Timuçin Kaşifoğlu

Abstract read
PubMed Publisher
In one paragraph

Article in Clinical rheumatology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Behçet's syndrome within the spectrum of systemic vasculitides.Saudi journal of ophthalmology : official journal of the Saudi Ophthalmological Society
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Reşit YıldırımDivision of Rheumatology, Department of Internal Medicine, Eskişehir Osmangazi University, School of Medicine, Eskişehir, Turkey. celeng18@gmail.com.ORCID http://orcid.org/0000-0003-4040-0212
Sedanur OğuzmanDepartment of Internal Medicine, Eskişehir Osmangazi University, School of Medicine, Eskişehir, Turkey.ORCID http://orcid.org/0000-0002-2732-2494
Mustafa DinlerDivision of Rheumatology, Department of Internal Medicine, Eskişehir Osmangazi University, School of Medicine, Eskişehir, Turkey.ORCID http://orcid.org/0000-0002-8133-8278
Nazife Şule Yaşar BilgeDivision of Rheumatology, Department of Internal Medicine, Eskişehir Osmangazi University, School of Medicine, Eskişehir, Turkey.ORCID http://orcid.org/0000-0002-0783-1072
Timuçin KaşifoğluDivision of Rheumatology, Department of Internal Medicine, Eskişehir Osmangazi University, School of Medicine, Eskişehir, Turkey.ORCID http://orcid.org/0000-0003-2544-8648
Eskişehir Osmangazi University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesPulmonary involvement other than pulmonary artery involvement in Behcet's disease still remains an area of investigation. The aim of this study was to evaluate pulmonary involvement associated with Behcet's disease.

methodWe retrospectively investigated all Behcet's disease patients in terms of pulmonary involvement. Twenty-eight patients, whose radiologic examinations were consistent with Behcet's disease-related involvement after excluding other possibilities, were included in this study. Data regarding demographic characteristics, other clinical components of Behcet's disease, treatment modalities, and types of pulmonary involvement were analyzed.

resultsPulmonary involvement was seen more common in male (82.1% vs 17.9%). Mean age for Behcet's disease diagnosis was found 32 years (SD 10.9) and mean age for pulmonary involvement was calculated 37 years (SD 11.4). Deep vein thrombosis (DVT) was the most common associated vascular involvement (53.6%). In our study population, alveolar hemorrhage and/or ground glass appearance were seen in 46.4% (13/28) of BD patients with pulmonary involvement. Totally, pulmonary artery aneurysm (PAA), small-sized pulmonary vasculitis (sPV), and pulmonary thrombosis (PT) were seen in 7 (25%), 13 (46.3%), and 18 (64.4%) of patients, respectively. Intracardiac thrombosis (ICT) in the right ventricle was present in 5 patients. Cyclophosphamide (CYC) was the most common preferred agent (78%) followed by azathioprine (AZA) in the first line. Warfarin was used in 18 patients. Overall mortality was seen in 3 patients: 1 due to PAA bleeding and others with unknown causes.

conclusionDespite the importance of pulmonary artery involvement and pulmonary thrombosis in Behcet's disease, small-sized pulmonary vasculitis in the form of small vessel involvement is generally overlooked. Our study findings have shown that alveolar hemorrhage and/or ground-glass appearance in the absence of pulmonary artery aneurysm and pulmonary thrombosis are seen commonly as well. Key Points • The characteristics of pulmonary small vasculature involvement in Behcet's disease which is still an area of investigation warrant further attention. • The clinician should bear in mind that the spectrum of pulmonary involvement in Behcet's disease may be variable, but an extensive work up is still of great importance especially in atypical cases.

Indexed as

AneurysmBehcet SyndromeLung DiseasesThrombosisVasculitisVenous ThrombosisAdultHemorrhageHumansMalePulmonary ArteryRetrospective StudiesBehcet’s diseaseClassificationOutcomePulmonary involvement

Identifiers

PMID36326947
OpenAlexW4308053325

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.